Vycor Medical (VYCO) EBITDA (2022 - 2023)
Vycor Medical (VYCO) has disclosed EBITDA for 6 consecutive years, with -$51904.0 as the latest value for Q3 2023.
- Quarterly EBITDA rose 54.79% to -$51904.0 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was -$91440.0 through Sep 2023, up 88.5% year-over-year, with the annual reading at -$2.5 million for FY2012, 42.98% up from the prior year.
- EBITDA for Q3 2023 was -$51904.0 at Vycor Medical, down from $68408.0 in the prior quarter.
- The five-year high for EBITDA was $68408.0 in Q2 2023, with the low at -$114806.0 in Q3 2022.